We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK.
Our Life Sciences industry is world leading, making a major contribution to the UK's economic strength…
Medicines are one of the greatest hopes we have for the future of human health, helping us live longer, helping us live better…
We have played our part in…
 Office for Life Sciences, Strength and Opportunity, 2015
 PwC UK, The Economic contribution of the UK Life Sciences industry , 2017
 ABPI / Clarivate, R&D Sourcebook, 2017
 World Bank, Life expectancy at birth, 2014
 Cancer Research UK, Cancer survival, 2017
 British Heart Foundation, BHF CVD Statistics Factsheet - UK, 2017
 Public Health England, HIV in the UK, 2016
 Adis, R&D Insight, 2016